Healthy VolunteersNCT07450989
Effects of Hip-Assist Exoskeleton Torque on Gait Parameters
A study testing ANGEL SUIT H10 (Hip-assist exoskeleton) in people with Healthy Volunteers and Robotic Exoskeleton, run by Yonsei University at 1 site in South Korea.
Trial summary
This study aims to evaluate the impact of assistive torque from a hip-assist exoskeleton on gait patterns in healthy adults. The investigators will analyze how different torque settings affect spatiotemporal parameters, joint kinematics, muscle activity (EMG), and foot pressure during walking. Read more about this study
- Who is it for?
- Ages 19 years and olderHealthy volunteers can take part
- Conditions the study is for
- Healthy Volunteers, Robotic Exoskeleton, Wearable Devices
- What is being tested?
- ANGEL SUIT H10 (Hip-assist exoskeleton)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 28 participants
- Where
- 1 siteSouth Korea
- Study dates
- 6 Jan 2026to 15 Jul 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Healthy adults aged 19 years or older without gait impairment.
- Body weight between 50kg and 100kg.
- No history of hip surgery.
- Capable of wearing a hip-assist exoskeleton.
- Voluntarily signed the informed consent form.
Who cannot join
- Skin or musculoskeletal issues that prevent wearing the exoskeleton.
- Inability to walk independently while wearing the exoskeleton.
- Other conditions deemed inappropriate by the investigator.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Assistive Hip Exoskeleton Torque on Spatiotemporal, Kinematic, Electromyographic, and Plantar Pressure Parameters During Walking in Healthy Adults
This study aims to evaluate the impact of assistive torque from a hip-assist exoskeleton on gait patterns in healthy adults. The investigators will analyze how different torque settings affect spatiotemporal parameters, joint kinematics, muscle activity (EMG), and foot pressure during walking.
- Conditions
- Healthy Volunteers, Robotic Exoskeleton, Wearable Devices, Assistive Devices, Biomechanics
- Being tested
- ANGEL SUIT H10 (Hip-assist exoskeleton)
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ANGEL SUIT H10 (Hip-assist exoskeleton)Device
A wearable robot that provides assistive torque (Flexion/Extension) to the hip joint during walking.
| Study group | Role | What they receive |
|---|---|---|
| Healthy Adult Group | Experimental | Healthy adult males and females aged 19 years or older, with a body weight ranging from 50 kg to 100 kg, who meet all inclusion criteria and have no history of hip surgery or gait impairment. Receives: Device: ANGEL SUIT H10 (Hip-assist exoskeleton) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Step Length
Distance between the point of initial contact of one foot and the point of initial contact of the opposite foot.
Unit: Meters (m)
Measured: Day 1
Stride Length
Distance between successive points of initial contact of the same foot. Unit: Meters (m)
Measured: Day 1
Cadence
Number of steps taken per minute. Unit: steps/min
Measured: Day 1
Gait Speed
verage walking speed during the 10-meter walk test. Unit: Meters per second (m/s)
Measured: Day 1
Single/Double Limb Support Phase
The duration of time when one or both feet are in contact with the ground. Unit: Percentage of gait cycle (% GC)
Measured: Day 1
Hip Joint Range of Motion
The maximum excursion of the hip joint in the sagittal plane during the gait cycle.
Unit: Degrees
Measured: Day 1
Knee Joint Range of Motion
The maximum excursion of the knee joint in the sagittal plane during the gait cycle.
Unit: Degrees
Measured: Day 1
Ankle Joint Range of Motion
The maximum excursion of the ankle joint in the sagittal plane during the gait cycle.
Unit: Degrees
Measured: Day 1
Secondary outcomes (7)
Muscle Activation of Rectus Femoris
Mean Root Mean Square (RMS) value of the rectus femoris muscle during the gait cycle.
Unit: Microvolts
Measured: Day 1
Muscle Activation of Vastus Medialis
Unit: Microvolts
Measured: Unit: Microvolts
Muscle Activation of Medial Hamstring
Unit: Microvolts
Measured: Day 1
Muscle Activation of Tibialis Anterior
Unit: Microvolts
Measured: Day 1
Muscle Activation of Gastrocnemius
Unit: Microvolts
Measured: Day 1
Peak Plantar Pressure
The maximum pressure recorded under the foot during the stance phase. Unit: N/cm^2
Measured: Day 1
Pressure-Time Integral (PTI)
The integral of pressure over the time of contact. Unit: Ns/cm^2
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Mar 2026
- Study start6 Jan 2026
- Primary completion15 Jul 2026
- Study completion15 Jul 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Healthy VolunteersStudies of the same condition, open and under way.
- More trials run by Yonsei UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 28 participants (actual)
Sponsor and investigators
- Lead sponsor
- Yonsei University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07450989
- Sponsor's protocol ID
- 1-2025-0068
- Status last verified
- Jul 2026
- First submitted
- 14 Jan 2026
- Last updated
- 28 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 28 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Assistive Hip Exoskeleton Torque on Spatiotemporal, Kinematic, Electromyographic, and Plantar Pressure Parameters During Walking in Healthy Adults
- ClinicalTrials.gov ID
- NCT07450989
- Acronym / sponsor ID
- 1-2025-0068
- Conditions
- Healthy Volunteers, Robotic Exoskeleton, Wearable Devices, Assistive Devices, Biomechanics
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 28 participants (actual)
- Lead sponsor
- Yonsei UniversityUniversity, hospital or other
- Study start
- 6 Jan 2026 (actual)
- Primary completion
- 15 Jul 2026 (actual)
- Study completion
- 15 Jul 2026 (actual)
- First posted
- 5 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the impact of assistive torque from a hip-assist exoskeleton on gait patterns in healthy adults. The investigators will analyze how different torque settings affect spatiotemporal parameters, joint kinematics, muscle activity (EMG), and foot pressure during walking.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Healthy Adult Group | Experimental | Device: ANGEL SUIT H10 (Hip-assist exoskeleton)Healthy adult males and females aged 19 years or older, with a body weight ranging from 50 kg to 100 kg, who meet all inclusion criteria and have no history of hip surgery or gait impairment. |
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Healthy adults aged 19 years or older without gait impairment.
- Body weight between 50kg and 100kg.
- No history of hip surgery.
- Capable of wearing a hip-assist exoskeleton.
- Voluntarily signed the informed consent form.
Key exclusion criteria (3 listed)
- Skin or musculoskeletal issues that prevent wearing the exoskeleton.
- Inability to walk independently while wearing the exoskeleton.
- Other conditions deemed inappropriate by the investigator.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ANGEL SUIT H10 (Hip-assist exoskeleton)A wearable robot that provides assistive torque (Flexion/Extension) to the hip joint during walking. | Device | Healthy Adult Group |
Primary outcome
Step Length
Time frame: Day 1
Distance between the point of initial contact of one foot and the point of initial contact of the opposite foot. Unit: Meters (m)
Stride Length
Time frame: Day 1
Distance between successive points of initial contact of the same foot. Unit: Meters (m)
Cadence
Time frame: Day 1
Number of steps taken per minute. Unit: steps/min
Gait Speed
Time frame: Day 1
verage walking speed during the 10-meter walk test. Unit: Meters per second (m/s)
Single/Double Limb Support Phase
Time frame: Day 1
The duration of time when one or both feet are in contact with the ground. Unit: Percentage of gait cycle (% GC)
Hip Joint Range of Motion
Time frame: Day 1
The maximum excursion of the hip joint in the sagittal plane during the gait cycle. Unit: Degrees
Knee Joint Range of Motion
Time frame: Day 1
The maximum excursion of the knee joint in the sagittal plane during the gait cycle. Unit: Degrees
Ankle Joint Range of Motion
Time frame: Day 1
The maximum excursion of the ankle joint in the sagittal plane during the gait cycle. Unit: Degrees
7 secondary outcomes
Muscle Activation of Rectus Femoris
Time frame: Day 1
Muscle Activation of Vastus Medialis
Time frame: Unit: Microvolts
Muscle Activation of Medial Hamstring
Time frame: Day 1
Muscle Activation of Tibialis Anterior
Time frame: Day 1
Muscle Activation of Gastrocnemius
Time frame: Day 1
Peak Plantar Pressure
Time frame: Day 1
Pressure-Time Integral (PTI)
Time frame: Day 1
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jul 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Healthy Volunteers
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Not yet recruitingObservational study
Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers
Healthy
RecruitingObservational study
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Graft-Versus-Host Disease, Graft-versus-leukemia
Not yet recruitingObservational study
Screening Protocol
Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ANGEL SUIT H10 (Hip-assist exoskeleton) in people with Healthy Volunteers and Robotic Exoskeleton, run by Yonsei University at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Step Length (time frame: Day 1). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2026.